Recent updates

  • 18 Jul 2019 WHO declares public health emergency over Ebola Topic: Ebola virus infection
  • 11 Jul 2019 US FDA approves brexanolone, the first drug approved specifically to treat postpartum depression Topic: Postpartum depression
  • 05 Jul 2019 EMA recommends restricting fluoroquinolone antibiotics to serious or life-threatening bacterial infections only Topic: Urinary tract infections in children
  • 09 May 2019 No new patients should start treatment with olaratumab Topic: Soft-tissue sarcoma
  • 08 May 2019 Comprehensive network meta-analysis provides guidance to inform choice of medication in GAD Topic: Generalized anxiety disorder
  • 25 Apr 2019 Placental growth factor (PIGF) test aids earlier preeclampsia diagnosis Topic: Preeclampsia
  • 18 Apr 2019 FDA approves trifluridine/tipiracil for metastatic gastric cancer after trial shows it improves survival Topic: Stomach cancer
  • 09 Apr 2019 FDA approves first therapy specifically for acquired thrombotic thrombocytopenic purpura Topic: Thrombotic thrombocytopenic purpura
  • 09 Apr 2019 Intravenous artesunate now first-line treatment for severe malaria in the US Topic: Malaria infection
  • 27 Mar 2019 US FDA approves eskatamine nasal spray for treatment-resistant depression in adults Topic: Depression in adults
  • 19 Mar 2019 Studies suggest minimally invasive surgery for early-stage cervical cancer results in lower 4-year survival rates Topic: Cervical cancer
  • 15 Mar 2019 FDA issues alert over link between breast implants and anaplastic large cell lymphoma Topic: Non-Hodgkin lymphoma
  • 14 Nov 2018 First-in-class treatment approved in the US for relapsed or refractory hairy cell leukemia Topic: Hairy cell leukemia
  • 20 Sep 2018 CDC alerts clinicians to a 'dramatic rise' in overdose deaths from fentanyl and its analogs Topic: Opioid overdose
  • 13 Jul 2018 European Medicines Agency (EMA) strengthens measures to avoid use of valproate medicines in pregnancy Topic: Bipolar disorder in children
  • 11 Oct 2017 Landmark cohort study on long-term antiplatelet treatment use in over-75s (post myocardial infarction/stroke/TIA) and risk of major GI bleeding Topic: Transient ischemic attack